Come up with a name for your new list and we'll add to it:
NutraTech raised a round of funding on , . Investors include
Braveheart Investment Group.
Nutratech is a worldwide licensee for Caldroitin , which is a patent-pending calcium chondroitin sulfate that meets FDA's sodium guidelines for "sodium-free." The core target for glucosamine chondroit…